181 related articles for article (PubMed ID: 1237619)
1. Morphine dependence and in vivo turnover of acetylcholine in whole mouse brain.
Cheney DL; Trabucchi M; Hanin I; Costa E
J Pharmacol Exp Ther; 1975 Nov; 195(2):288-95. PubMed ID: 1237619
[TBL] [Abstract][Full Text] [Related]
2. Application of principles of steady-state kinetics to the estimation of brain acetylcholine turnover rate: effects of oxotremorine and physostigmine.
Trabucchi M; Cheney DL; Hanin I; Costa E
J Pharmacol Exp Ther; 1975 Jul; 194(1):57-64. PubMed ID: 1151756
[TBL] [Abstract][Full Text] [Related]
3. Brain acetylcholine and choline following acute and chronic morphine treatment and during withdrawal.
Bhargava HN; Way EL
J Pharmacol Exp Ther; 1975 Jul; 194(1):65-73. PubMed ID: 1171222
[TBL] [Abstract][Full Text] [Related]
4. Relationship between incorporation of choline into phosphatidylcholine and morphine binding sites.
Natsuki R
Arukoru Kenkyuto Yakubutsu Ison; 1992 Feb; 27(1):57-70. PubMed ID: 1317702
[TBL] [Abstract][Full Text] [Related]
5. Reinitiation of sensitivity to naloxone by a single narcotic injection in postaddicted mice.
Brase DA; Iwamoto ET; Loh HH; Way EL
J Pharmacol Exp Ther; 1976 May; 197(2):317-25. PubMed ID: 944771
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the effects of naloxone upon body weight loss and suppression of fixed-ratio operant behavior in morphine-dependent rats.
Gellert VF; Sparber SB
J Pharmacol Exp Ther; 1977 Apr; 201(1):44-54. PubMed ID: 557543
[TBL] [Abstract][Full Text] [Related]
7. Brain acetylcholine in morphine pellet implanted rats given naloxone.
Domino EF; Wilson AE
Psychopharmacologia; 1975; 41(1):19-22. PubMed ID: 1168354
[TBL] [Abstract][Full Text] [Related]
8. Glucose utilization in the rat brain during chronic morphine treatment and naloxone-precipitated morphine withdrawal.
Kimes AS; London ED
J Pharmacol Exp Ther; 1989 Feb; 248(2):538-45. PubMed ID: 2918470
[TBL] [Abstract][Full Text] [Related]
9. Application of principles of steady-state kinetics to the in vivo estimation of acetylcholine turnover rate in mouse brain.
Cheney DL; Costa E; Hanin I; Trabucchi M; Wang CT
J Pharmacol Exp Ther; 1975 Feb; 192(2):288-96. PubMed ID: 1117417
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic influence on withdrawal jumping behavior in morphine-dependent mice.
Tseng LF; Brase DA; Loh HH
Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):435-46. PubMed ID: 1033590
[TBL] [Abstract][Full Text] [Related]
11. Elevation of brain dopamine during naloxone-precipitated withdrawal in morphine-dependent mice and rats.
Iwamoto ET; Ho IK; Way EL
J Pharmacol Exp Ther; 1973 Dec; 187(3):588-67. PubMed ID: 4797745
[No Abstract] [Full Text] [Related]
12. Further studies on the enhanced affinity of opioid receptors for naloxone in morphine-dependent mice.
Kitano T; Takemori AE
J Pharmacol Exp Ther; 1979 Jun; 209(3):456-61. PubMed ID: 220409
[No Abstract] [Full Text] [Related]
13. Effect of 1-phenyl-3-(2-thiazolyl)-2-thiourea, a dopamine beta-hydroxylase inhibitor on morphine analgesia, tolerance and physical dependence.
Bhargava HN; Way EL
J Pharmacol Exp Ther; 1974 Jul; 190(1):165-75. PubMed ID: 4858783
[No Abstract] [Full Text] [Related]
14. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.
Zarrindast MR; Mohajeri S
Eur J Pharmacol; 2006 Dec; 552(1-3):90-8. PubMed ID: 17049514
[TBL] [Abstract][Full Text] [Related]
15. Naloxone increases vascular responsiveness in chronic morphine treated rats and facilitates intracellular signaling in cultured vascular cells.
Wang Y; Xu JG; Yu YQ; Wang HY; Jiang B; Li XY
Acta Pharmacol Sin; 2001 Oct; 22(10):881-6. PubMed ID: 11749769
[TBL] [Abstract][Full Text] [Related]
16. Effects of acute and chronic morphine treatments on calcium localization and binding in brain.
Yamamoto H; Harris RA; Loh HH; Way EL
J Pharmacol Exp Ther; 1978 May; 205(2):255-64. PubMed ID: 565404
[TBL] [Abstract][Full Text] [Related]
17. Tolerance to and physical dependence on morphine: relation to neocortical acetylcholine release in the cat.
Labrecque G; Domino EF
J Pharmacol Exp Ther; 1974 Oct; 191(1):189-200. PubMed ID: 4473036
[No Abstract] [Full Text] [Related]
18. A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat.
Lee PH; McNutt RW; Chang KJ
J Pharmacol Exp Ther; 1993 Nov; 267(2):883-7. PubMed ID: 8246163
[TBL] [Abstract][Full Text] [Related]
19. Modification of brain and spinal cord dopamine D1 receptors labeled with [3H]SCH 23390 after morphine withdrawal from tolerant and physically dependent rats.
Bhargava HN; Gulati A
J Pharmacol Exp Ther; 1990 Mar; 252(3):901-7. PubMed ID: 2138669
[TBL] [Abstract][Full Text] [Related]
20. In alcohol-treated rats, naloxone decreases extracellular dopamine and increases acetylcholine in the nucleus accumbens: evidence of opioid withdrawal.
Rada P; Johnson DF; Lewis MJ; Hoebel BG
Pharmacol Biochem Behav; 2004 Dec; 79(4):599-605. PubMed ID: 15582668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
